Home › Nasopharyngeal Carcinoma › South Carolina
Nasopharyngeal Carcinoma clinical trials in South Carolina
3 studies for Nasopharyngeal Carcinoma are looking for participants at sites in South Carolina.
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
- Medical University of South Carolina, Charleston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06029270A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
- Prisma Health Richland Hospital, Columbia
- BI-LO Charities Children's Cancer Center, Greenville
RecruitingPhase 2
Up to age 21 · All sexes · Updated Sep 14, 2026 · NCT06064097Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Lancaster Radiation Therapy Center, Lancaster
- Rock Hill Radiation Therapy Center, Rock Hill
- Levine Cancer Institute-Rock Hill, Rock Hill
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06532279From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.